We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
On 20 October 2020, Sihuan Pharmaceutical Holdings Group Ltd. announced that its participation in the investment of Phase I Fund of Ascendum Capital Life Technology.